Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use | MicrobiomeTrials
Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use
TERMINATEDPHASE4INTERVENTIONAL
Trial Details
Start: 2024-07-15Est. Completion: 2025-05-22
Enrollment target: 1 participants
Locations
University of Maryland Medical Center, Baltimore, Maryland, United States
Other microbiome trials you might be interested in